Shiladitya Sengupta

Shiladitya Sengupta is currently serving as an Associate Professor of Medicine at Harvard Medical School and an Assistant Professor of Health Sciences and Technology at Massachusetts Institute of Technology. Additionally, Shiladitya is the Founder of Alyssum Therapeutics, Co-founder of Vyome Therapeutics Inc., and a Board Member at Famy Life Sciences. In the past, Shiladitya has co-founded Cerulean Pharmaceuticals and served as Co-chair at the Center for Regenerative Therapeutics at BRI-Brigham and Women's Hospital. Shiladitya holds a Fellowship in Biological Engineering from the Massachusetts Institute of Technology, a PhD in Pharmacology from the University of Cambridge, and BS and MS degrees in Pharmacology from All India Institute of Medical Sciences.